Company Filing History:
5 out of 6 
5 out of 5 
3 out of 3 Years Active: 2021-2025
Title: The Innovative Contributions of Runsheng Li
Introduction
Runsheng Li is a prominent inventor based in Shanghai, China, known for his significant contributions to the field of cancer treatment. With a total of 13 patents to his name, he has made remarkable strides in developing innovative therapies that target specific proteins involved in cancer progression.
Latest Patents
One of his latest patents focuses on methods of treating cancer by administering an antibody-drug conjugate that targets human claudin 18.2. This patent provides detailed information about antibody-drug conjugates that contain a drug moiety attached to an antibody or fragment that specifically binds to the wild-type human claudin 18.2 protein. The binding occurs at the β3-β4 loop and the β5 strand of the CLDN18.2 protein, which is crucial for the development of effective cancer therapies.
Career Highlights
Throughout his career, Runsheng Li has worked with various companies, including Lanova Medicines Limited. His work has been instrumental in advancing the understanding and treatment of cancer through innovative drug development.
Collaborations
Runsheng Li has collaborated with notable colleagues, including Wentao Huang and Ying Qin Zang, to further enhance the research and development of cancer therapies.
Conclusion
Runsheng Li's innovative work in the field of cancer treatment exemplifies the impact of targeted therapies in modern medicine. His contributions continue to pave the way for advancements in cancer research and treatment options.